Company
Avego BioScience Capital
Investments
| Company | Round | Date | Lead |
|---|---|---|---|
| Memento Medicines | Series A | 2026-06-19 | Lead |
| Alveus Therapeutics Inc. | Series A | 2026-03-02 | |
| Alveus Therapeutics Inc. | Series A | 2026-01-08 | |
| TRexBio | Series B | 2024-11-14 | |
| Evommune | Series C Funding | 2024-10-31 |